ArticleApoptosis : an international journal on programmed cell death2026
IRF1-mediated sensing of oxidized mitochondrial DNA drives macrophage PANoptosis in lung ischemia-reperfusion injury.
Article in Apoptosis : an international journal on programmed cell death, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Lung ischemia-reperfusion injury (IRI), a significant factor contributing to early mortality following lung transplantation (LTx), is driven by molecular mechanisms that are not yet fully understood. In this study, we elucidate a crucial signaling pathway initiated by extracellular histones (ex-His), which connects mitochondrial damage to inflammatory cell death. Through the use of a murine model of lung IRI and in vitro experiments with alveolar macrophages, we demonstrate that ex-His facilitate Drp1-dependent mitochondrial fission, resulting in the release of oxidized mitochondrial DNA (ox-mtDNA) into the cytosol. Our mechanistic analysis reveals that cytosolic ox-mtDNA is detected by the transcription factor IRF1, which subsequently upregulates NLRC5 at the transcriptional level. Additionally, we identify NLRC5 as a non-canonical scaffold that is essential for the assembly of the PANoptosome, a multi-protein complex that mediates PANoptosis, an inflammatory cell death pathway that aggravates tissue damage. The clinical relevance of this pathway was then examined in lung transplant recipients. An analysis of their peripheral blood mononuclear cells (PBMCs) revealed that patients who developed primary graft dysfunction (PGD) exhibited markedly elevated levels of circulating histones and cytosolic ox-mtDNA. This was associated with hyperactivation of the core signaling axis, characterized by increased Drp1 phosphorylation and elevated expression of IRF1 and NLRC5. Collectively, our study elucidates a comprehensive pathogenic cascade from an extracellular danger signal to a specific cell death program, identifying the ex-His-mitochondria-IRF1-NLRC5 axis as a critical driver of macrophage PANoptosis and a promising therapeutic target for alleviating lung IRI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.